Reduced Intensity Conditioning (RIC) Regimen for Patients With Non-malignant Disorders (RIC)
Sponsor: Children's Hospital of Philadelphia
This PHASE2 trial investigates Hemoglobinopathies and Immunodeficiencies and is currently ongoing. Children's Hospital of Philadelphia leads this study, which shows 13 recorded versions since 2008 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Active Not Recruiting PHASE2
-
Aug 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE2
-
Jul 2024 — Aug 2024 [monthly]
Active Not Recruiting PHASE2
-
Mar 2024 — Jul 2024 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Apr 2023 — Mar 2024 [monthly]
Recruiting PHASE2
▶ Show 8 earlier versions
-
Apr 2022 — Apr 2023 [monthly]
Recruiting PHASE2
-
Apr 2021 — Apr 2022 [monthly]
Recruiting PHASE2
-
Jan 2021 — Apr 2021 [monthly]
Recruiting PHASE2
-
Mar 2020 — Jan 2021 [monthly]
Recruiting PHASE2
-
Apr 2019 — Mar 2020 [monthly]
Recruiting PHASE2
-
Jun 2018 — Apr 2019 [monthly]
Recruiting PHASE2
-
Feb 2017 — Jun 2018 [monthly]
Recruiting PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE2
First recorded
Jan 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Children's Hospital of Philadelphia
For direct contact, visit the study record on ClinicalTrials.gov .